Importance of radiotherapy for gastric cancer;Place de la radiotherapie dans les cancers de l'estomac

Bulletin du Cancer

Volumn 84, Issue 9, 1997, Pages 913-916

  Bleiberg, H ^a   Jeziorsky, K ^b   Hendlisz, A ^a   Gerard, B ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

cancer; chemotherapy; gastric; radiotherapy

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOMYCIN C; SEMUSTINE;

CHEMOTHERAPY; HUMAN; METHODOLOGY; REVIEW; STOMACH CANCER; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; CANCER STAGING; CLINICAL TRIAL; META ANALYSIS; MULTIMODALITY CANCER THERAPY; PALLIATIVE THERAPY; PATHOLOGY; RADIATION DOSE; STOMACH TUMOR; SURVIVAL; TREATMENT OUTCOME;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM STAGING; PALLIATIVE CARE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0030863840     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Gunderson IL, Sosin H. Adenocarcinoma of stomach : areas of failure in a reoperation series (second or symptomatic looks) : clinicopathologic correlation and implications for adjuvant therapy. Int J Rod Oncol Biol Phys 1982 ; 8 : 1-11.
2. Caudry M. Gastric cancer : radiotherapy and approaches to locally unresectable recurrent disease. In : Ahlgren JD, MacDonald JS, eds. Gastrointestinal oncology. Lippincott : Philadelphia 1992 ; 181-7.
3. Caudry M, Escarmant P, Maire JP. Radiotherapy of gastric cancer with a three field combination : feasibility, tolerance and survival. Int J Rad Oncol Biol Phys 1987 ; 13 : 1821-7.
4. Dent DM, Werner ID, Novis B, Cherverton P, Brice P. Prospective randomized trial of combined oncological therapy for gastric carcinoma. Cancer 1979 ; 44 : 385-91.
5. Moertel CG, Childs DS, O'Fallon JR, Hallbroock MA, Schutt AJ, Reitemeir RJ. Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma. J Clin Oncol 1984 ; 2 : 1249-55.
6. Bleiberg H, Goffin JC, Dalesio O, et al. Adjuvant radiotherapy and chemotherapy in resectable gastric cancer. Eur J Surg Oncol 1989 ; 15 : 535-43.
7. Allum WH, Hallissey MT, Ward LC, Hockey MS. A controlled prospective, randomized trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. Br J Cancer 1989 ; 60 : 739-44.
8. Hallissey MT, Dunn JA, Ward LC, Allum WH. The second british stomach cancer group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet 1994 ; 343 : 1309-12.
9. Hazel JJ, Thirlwell MP, Huggins M et al. Multi-drug chemotherapy with and without radiation for carcinoma of the stomach and the pancreas - a prospective randomized trial. J Can Assoc Radiol 1981 ; 32 : 164-5.
10. Gastrointestinal Tumor Study Group. A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma. Cancer 1982 ; 49 : 1771-7.
11. Klaassen DJ, MacIntyre JM, Catton GE, Engstrom PF, Moertel CG. Treatment of locally unresectable cancer of stomach and pancreas : a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil - an Eastern Cooperative Oncology Group Study J Clin Oncol 1985 ; 3 : 373-8.
12. Bleiberg H, Gerard B, Deguiral P. Adjuvant therapy in resectable gastric cancer. Brit J Cancer 1992 ; 66 ; 987-91.
13. Childs DS, Mortel CG, Holbrook MA, Reitemeier RJ, Colby M Jr. Treatment of unresectable adenocarcinomas of the stomach with a combination of 5-fluorouracil and radiation. Am J Roentgenol Radium Ther Nucl Med 1968 ; 102 : 541-4.
14. Moertel CG, Childs DS Jr, Reitemeier RJ, Colby MY Jr, Holbrook MA. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969 ; 25 : 865-7.
15. Falkson G, Falkson HC. Fluorouracil and radiotherapy in gastrointestinal cancer. Lancet 1969 ; 6 : 1252-3.
16. The Gastrointestinal Tumor Study Group. The concept of locally advanced gastric cancer. Cancer 1990 ; 1 : 2324-30.
17. Shchepotin IB, Evans SR, Chorny V, et al. Intensive preopetative radiotherapy with local hyperthermia for the treatment of gastric carcinoma. Surg Oncol 1994 ; 3 : 37-44.
18. Eeftinck M, Obertop H, Mudt WM, Eijkenboom WMH, Von Andel JG, Van Houten H. Survival after resection for carcinoma of the oesophagus. Br J Surg 1987 ; 74 : 165-8.
19. Flores AD, Nelems B, Evans K, Hay JH, Stoller J, Jackson SM. Impact of new radiotherapy modalities on the surgical management of cancer of the esophagus and cardia. Int J Radiat Oncol Biol Phys 1989 ; 17 : 937-44.
20. Gill PG, Jamieson GG, Denham J, et al. Treatment of adenocarcinoma of the cardia with synchronous chemotherapy and radiotherapy Br J Surg 1990 ; 77 : 1020-3.
21. Abe M, Takahashi M, Yabumoto E, Adachi H, Yoshii M, Mori K. Clinical experiences with intraoperative radiotherapy of locally advanced cancers. Cancer 1980 ; 45 : 40-5.
22. Calvo F, Javier Aristu J, Azinovic I, et al. Intraoperative and external radiotherapy in resected gastric cancer updated report of a phase II trial. Int J Radiat Oncol Biol Phys 1992 ; 24 : 729-36.
23. Sindelar WF, Kinsella TJ, Tepper JE, et al. Randomized trial of intraoperative radiotherapy in carcinoma of the stomach. Am J Surg 1993 ; 165 : 178-87.
24. Cuschieri A, Foyers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet 1996 ; 347 : 995-9.